Trump’s 100% tariff on pharma will not impact generic makers: IPA
New Delhi: Indian Pharmaceutical Alliance (IPA) Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines. Reacting to the development, IPA Secretary General Sudarshan Jain...










































